The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Human natural killer cell development and biology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Self-citationBiology of Natural Killer Cells
Trinchieri, G. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60664-1 · Cited by 2,902
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768
Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161501 · Cited by 2,735
In search of the ‘missing self’: MHC molecules and NK cell recognition
Ljunggren, H.-G., & Kärre, K. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90097-s · Cited by 2,687
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Self-citationLicensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain
Cao, X., Shores, E. W., Hu-Li, J., Anver, M. R., Kelsail, B. L., Russell, S. M., Drago, J., Noguchi, M., Grinberg, A., Bloom, E. T., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90047-0 · Cited by 1,038
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Interleukin 15: biology and relevance to human disease
Fehniger, T. A., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.1.14 · Cited by 976
Self-citationCostimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells
Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., & Spies, T. (2001) · Nature Immunology · doi:10.1038/85321 · Cited by 951
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
McKenna, H. J., Stocking, K. L., Miller, R. E., Brasel, K., De Smedt, T., Maraskovsky, E., Maliszewski, C. R., Lynch, D. H., Smith, J., Pulendran, B., et al. (2000) · Blood · doi:10.1182/blood.v95.11.3489 · Cited by 932
Biology and clinical relevance of human natural killer cells
Robertson, M., & Ritz, J. (1990) · Blood · doi:10.1182/blood.v76.12.2421.2421 · Cited by 931
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
Schorle, H., Holtschke, T., Hünig, T., Schimpl, A., & Horak, I. (1991) · Nature · doi:10.1038/352621a0 · Cited by 879
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
DiSanto, J. P., Müller, W., Guy-Grand, D., Fischer, A., & Rajewsky, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.377 · Cited by 866
Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., & Caligiuri, M. A. (2003) · Blood · doi:10.1182/blood-2002-09-2876 · Cited by 857
Self-citationYokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S.-I., & Gruss, P. (1999) · Nature · doi:10.1038/17812 · Cited by 850
Ashkar, A. A., Di Santo, J. P., & Croy, B. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.259 · Cited by 845
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80393-3 · Cited by 732
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 726
c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities
Lyman, S. D., & Jacobsen, S. E. W. (1998) · Blood · doi:10.1182/blood.v91.4.1101 · Cited by 696
Comparative studies of human FcRIII-positive and negative natural killer cells.
Nagler, A., Lanier, L. L., Cwirla, S., & Phillips, J. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.10.3183 · Cited by 696
A Novel Immunoglobulin Superfamily Receptor for Cellular and Viral MHC Class I Molecules
Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L., & Hsu, M.-L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80529-4 · Cited by 695
Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., & Belardelli, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1777 · Cited by 643
Cerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A., & Münz, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1455 · Cited by 589
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Mrozek, E., Anderson, P., & Caligiuri, M. (1996) · Blood · doi:10.1182/blood.v87.7.2632.bloodjournal8772632 · Cited by 492
Self-citationMattei, F., Schiavoni, G., Belardelli, F., & Tough, D. F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1179 · Cited by 459
Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A., & Biassoni, R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.787 · Cited by 452
Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L., & Phillips, J. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4741 · Cited by 447
Houchins, J. P., Yabe, T., McSherry, C., & Bach, F. H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.1017 · Cited by 447
Caligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., & Ritz, J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1509 · Cited by 435
Self-citationRecognition of viral hemagglutinins by NKp44 but not by NKp30
Arnon, T. I., Lev, M., Katz, G., Chernobrov, Y., Porgador, A., & Mandelboim, O. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200109)31:9<2680::aid-immu2680>3.0.co;2-a · Cited by 429
Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O., & Wagtmann, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.571 · Cited by 422
A Human CD34(+) Subset Resides in Lymph Nodes and Differentiates into CD56brightNatural Killer Cells
Freud, A. G., Becknell, B., Roychowdhury, S., Mao, H. C., Ferketich, A. K., Nuovo, G. J., Hughes, T. L., Marburger, T. B., Sung, J., Baiocchi, R. A., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.013 · Cited by 401
Self-citationNavarro, F., Llano, M., Bellón, T., Colonna, M., Geraghty, D. E., & López-Botet, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<277::aid-immu277>3.0.co;2-4 · Cited by 366
Identification of committed NK cell progenitors in adult murine bone marrow
Rosmaraki, E. E., Douagi, I., Roth, C., Colucci, F., Cumano, A., & Di Santo, J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200106)31:6<1900::aid-immu1900>3.0.co;2-m · Cited by 364
Armeanu, S., Bitzer, M., Lauer, U. M., Venturelli, S., Pathil, A., Krusch, M., Kaiser, S., Jobst, J., Smirnow, I., Wagner, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4252 · Cited by 358
Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H., & Ritz, J. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.3.779 · Cited by 354
Suzuki, H., Duncan, G. S., Takimoto, H., & Mak, T. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.499 · Cited by 351
A human killer inhibitory receptor specific for HLA-A1,2
Döhring, C., Scheidegger, D., Samaridis, J., Cella, M., & Colonna, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3098 · Cited by 349
Carson, W. E., Ross, M. E., Baiocchi, R. A., Marien, M. J., Boiani, N., Grabstein, K., & Caligiuri, M. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118321 · Cited by 348
Self-citationNatural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
Dorshkind, K., Pollack, S. B., Bosma, M. J., & Phillips, R. A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.3798 · Cited by 346
Mandelboim, O., Reyburn, H. T., Valés-Gómez, M., Pazmany, L., Colonna, M., Borsellino, G., & Strominger, J. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.913 · Cited by 338
Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
Human natural killer cell receptors and co‐receptors
Biassoni, R., Cantoni, C., Pende, D., Sivori, S., Parolini, S., Vitale, M., Bottino, C., & Moretta, A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810117.x · Cited by 324
Frey, M., Packianathan, N. B., Fehniger, T. A., Ross, M. E., Wang, W.-C., Stewart, C. C., Caligiuri, M. A., & Evans, S. S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.400 · Cited by 287
Self-citationCarretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodríguez, A., Pérez‐Villar, J. J., Moretta, L., Moretta, A., & López‐Botet, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270230 · Cited by 281
Interleukin-2 and interleukin-15: immunotherapy for cancer
Fehniger, T. A., Cooper, M. A., & Caligiuri, M. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00021-1 · Cited by 280
Self-citationAllelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype
Shilling, H. G., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Rodriguez, R., Tyan, D., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2307 · Cited by 275
Caligiuri, M. A., Murray, C., Robertson, M. J., Wang, E., Cochran, K., Cameron, C., Schow, P., Ross, M. E., Klumpp, T. R., & Soiffer, R. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116161 · Cited by 269
Self-citationNKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
Brooks, A. G., Posch, P. E., Scorzelli, C. J., Borrego, F., & Coligan, J. E. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.795 · Cited by 262
Uhrberg, M., Parham, P., & Wernet, P. (2002) · Immunogenetics · doi:10.1007/s00251-002-0463-7 · Cited by 260
Rajagopalan, S., Fu, J., & Long, E. O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1877 · Cited by 258
Santourlidis, S., Trompeter, H.-I., Weinhold, S., Eisermann, B., Meyer, K. L., Wernet, P., & Uhrberg, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4253 · Cited by 253
Yu, H., Fehniger, T. A., Fuchshuber, P., Thiel, K. S., Vivier, E., Carson, W. E., & Caligiuri, M. A. (1998) · Blood · doi:10.1182/blood.v92.10.3647 · Cited by 237
Self-citationReversal of natural killing susceptibility in target cells expressing transfected class I HLA genes.
Storkus, W. J., Alexander, J., Payne, J. A., Dawson, J. R., & Cresswell, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2361 · Cited by 236
Nagler, A., Lanier, L. L., & Phillips, J. H. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1527 · Cited by 223
DNA Methylation Maintains Allele-specific KIR Gene Expression in Human Natural Killer Cells
Chan, H.-W., Kurago, Z. B., Stewart, C. A., Wilson, M. J., Martin, M. P., Mace, B. E., Carrington, M., Trowsdale, J., & Lutz, C. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021127 · Cited by 221
MIC Genes: From Genetics to Biology
Bahram, S. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76018-x · Cited by 219
Ciccone, E., Pende, D., Viale, O., Than, A., Di Donato, C., Orengo, A. M., Biassoni, R., Verdiani, S., Amoroso, A., & Moretta, A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.4.963 · Cited by 214
Nowbakht, P., Ionescu, M.-C. S., Rohner, A., Kalberer, C. P., Rossy, E., Mori, L., Cosman, D., De Libero, G., & Wodnar-Filipowicz, A. (2005) · Blood · doi:10.1182/blood-2004-07-2585 · Cited by 196
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15950 · Cited by 180
Gumperz, J. E., Barber, L. D., Valiante, N. M., Percival, L., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5237 · Cited by 179
Carson, W. E., Parihar, R., Lindemann, M. J., Personeni, N., Dierksheide, J. E., Meropol, N. J., Baselga, J. M., & Caligiuri, M. A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j · Cited by 175
Self-citationAnsell, S. M., Witzig, T. E., Kurtin, P. J., Sloan, J. A., Jelinek, D. F., Howell, K. G., Markovic, S. N., Habermann, T. M., Klee, G. G., Atherton, P. J., et al. (2002) · Blood · doi:10.1182/blood.v99.1.67 · Cited by 164
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215950 · Cited by 164
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
Koh, C. Y., Blazar, B. R., George, T., Welniak, L. A., Capitini, C. M., Raziuddin, A., Murphy, W. J., & Bennett, M. (2001) · Blood · doi:10.1182/blood.v97.10.3132 · Cited by 160
A Cluster of Ten Novel MHC Class I Related Genes on Human Chromosome 6q24.2–q25.3
Radosavljevic, M., Cuillerier, B., Wilson, M. J., Clément, O., Wicker, S., Gilfillan, S., Beck, S., Trowsdale, J., & Bahram, S. (2002) · Genomics · doi:10.1006/geno.2001.6673 · Cited by 160
Sutherland, C. L., Chalupny, N. J., & Cosman, D. J. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810115.x · Cited by 152
Hank, J. A., Robinson, R. R., Surfus, J. E., Mueller, B. M., Reisfeld, R. A., Cheung, N. K., & Sondel, P. M. (1990) · PubMed · Cited by 151
Leung, W. H., Iyengar, R. V., Triplett, B. M., Turner, V., Behm, F. G., Holladay, M., Houston, J., & Handgretinger, R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6540 · Cited by 148
Differentiation of NK1.1+, Ly49+ NK Cells from flt3+ Multipotent Marrow Progenitor Cells
Williams, N. S., Klem, J., Puzanov, I. J., Sivakumar, P. V., Bennett, M., & Kumar, V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2648 · Cited by 148
Long, E. O., Barber, D. F., Burshtyn, D. N., Faure, M., Peterson, M., Rajagopalan, S., Renard, V., Sandusky, M., Stebbins, C. C., Wagtmann, N. R., et al. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810119.x · Cited by 146
Baume, D. M., Robertson, M. J., Levine, H., Manley, T. J., Schow, P. W., & Ritz, J. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220102 · Cited by 145
Williams, N., Klem, J., Puzanov, I., Sivakumar, P., Schatzle, J., Bennett, M., & Kumar, V. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01229.x · Cited by 142
Friedberg, J. W., Neuberg, D. S., Gribben, J. G., Fisher, D. C., Canning, C. M., Koval, M. A., Poor, C. M., Green, L. M., Daley, J. F., Soiffer, R. J., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03535.x · Cited by 140
Shimizu, Y., & DeMars, R. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190306 · Cited by 135
KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells
Goodridge, J. P., Witt, C. S., Christiansen, F., & Warren, H. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.4.1768 · Cited by 132
Kumar, V. B., Ben‐Ezra, J. M., Bennett, M. V. L., et al. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.123.4.1832 · Cited by 129
Seaman, W. E., Gindhart, T. D., Greenspan, J. S., et al. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.6.2541 · Cited by 128
Glienke, J., Sobanov, Y., Brostjan, C., Steffens, C., Nguyen, C., Lehrach, H., Hofer, E., & Francis, F. (1998) · Immunogenetics · doi:10.1007/s002510050420 · Cited by 120
MIC and other NKG2D ligands: from none to too many
Bahram, S., Inoko, H., Shiina, T., & Radosavljevic, M. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.07.016 · Cited by 116
The IL-12 Signature: NK Cell Terminal CD56+high Stage and Effector Functions
Loza, M. J., & PERUSSIA, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.88 · Cited by 114
Torkar, M., Norgate, Z., Colonna, M., Trowsdale, J., & Wilson, M. J. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12<3959::aid-immu3959>3.0.co;2-2 · Cited by 113
Functions of Human Decidual NK Cells
King, A., Jokhi, P., Burrows, T. D., Gardner, L., Sharkey, A., & Lore, Y. W. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00041.x · Cited by 103
Shibuya, A., Nagayoshi, K., Nakamura, K., & Nakauchi, H. (1995) · Blood · doi:10.1182/blood.v85.12.3538.bloodjournal85123538 · Cited by 93
Bernstein, Z., Porter, M., Gould, M., Lipman, B., Bluman, E., Stewart, C., Hewitt, R. M., Fyfe, G., Poiesz, B. J., & Caligiuri, M. A. (1995) · Blood · doi:10.1182/blood.v86.9.3287.bloodjournal8693287 · Cited by 92
Self-citationColucci, F., & Santo, J. P. D. (2000) · Blood · doi:10.1182/blood.v95.3.984.003k40_984_991 · Cited by 91
Crystal Structure of the Human Natural Killer Cell Activating Receptor KIR2DS2 (CD158j)
Saulquin, X., Gastinel, L. N., & Vivier, É. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021624 · Cited by 91
Malnati, M., Lusso, P., Ciccone, E., Moretta, A., Moretta, L., & Long, E. O. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.3.961 · Cited by 83
Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors
Lotzová, E., Savary, C. A., & Champlin, R. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5263 · Cited by 82
Immunology of human placental implantation: clinical implications of our current understanding
Loke, Y. W., & King, A. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01011-3 · Cited by 80
Rojo, S., Wagtmann, N. R., & Long, E. O. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270231 · Cited by 65
Sedlmayr, P., Schallhammer, L., Hammer, A., Wilders‐Truschnig, M. M., Wintersteiger, R., & Dohr, G. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237321 · Cited by 61
Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell
PERUSSIA, B., Chen, Y., & Loza, M. J. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.017 · Cited by 58
The CD94/NKG2 C-Type Lectin Receptor Complex
López‐Botet, M., Carretero, M., Bellón, T., Pérez‐Villar, J. J., Llano, M., & Navarro, F. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_4 · Cited by 51
Farag, S. S., George, S. L., Lee, E. J., Baer, M. R., Dodge, R. K., Becknell, B., Fehniger, T. A., Silverman, L. R., Crawford, J., Bloomfield, C. D., et al. (2002) · PubMed · Cited by 49
Self-citationRoutes, J. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.7.2372 · Cited by 34
Ontogeny and Expansion of Human Natural Killer Cells: Clinical Implications
Fehniger, T. A., & Caligiuri, M. A. (2001) · International Reviews of Immunology · doi:10.3109/08830180109054417 · Cited by 33
Self-citationPiguet, P., Grau, G. E., Irlé, C., & VASSALLI, P. (1986) · European Journal of Immunology · doi:10.1002/eji.1830161012 · Cited by 28
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
Parihar, R., Dierksheide, J., Hu, Y., & Carson, W. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215950 · Cited by 23
Relationship between target cell cycle and susceptibility to natural killer lysis.
LANDAY, A. L., Zarcone, D., Grossi, C. E., et al. (1987) · PubMed · Cited by 18
Pollack, S. B., Tsuji, J. M., & Rosse, C. (1992) · Cellular Immunology · doi:10.1016/0008-8749(92)90077-3 · Cited by 13
Cited by
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543
Parkhurst, M. R., Riley, J. P., Dudley, M. E., & Rosenberg, S. A. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1347 · Cited by 475
Kopp, H.-G., Placke, T., & Salih, H. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2123 · Cited by 469
Relationship between CD107a expression and cytotoxic activity
Aktas, E., Kucuksezer, U. C., Bilgic, S., Erten, G., & Deniz, G. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2008.08.007 · Cited by 465
Metadata
- Authors
- Farag, S. S., & Caligiuri, M. A.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 2006-05
- Volume
- 20
- Issue
- 3
- Pages
- 123-137
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2025635581
- Cited by
- 506
- References
- 119
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.